首页> 外文期刊>Pediatric Cardiology >Beraprost Therapy in Children with Pulmonary Hypertension Secondary to Congenital Heart Disease
【24h】

Beraprost Therapy in Children with Pulmonary Hypertension Secondary to Congenital Heart Disease

机译:先天性心脏病继发性肺动脉高压患儿的贝拉前列素治疗

获取原文
获取原文并翻译 | 示例
           

摘要

We present a report on children with severe pulmonary hypertension secondary to congenital heart disease who received 6 months of beraprost therapy. The children had an increase in intracardiac left-to-right shunt and a reduction of the pulmonary-to-systemic vascular resistance ratio, whereas the pulmonary artery pressure was not significantly changed.
机译:我们提供了一份关于接受先天性贝拉前列素治疗六个月的先天性心脏病继发性严重肺动脉高压儿童的报告。儿童的心内从左到右分流增加,肺与全身的血管阻力比降低,而肺动脉压没有明显改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号